Tag Archives: Johns Hopkins University

TB Alliance Sublicenses Promising Anti-Tuberculosis Drug from the Medicines Patent Pool

Herman Opondo On World Tuberculosis Day, TB Alliance and the Medicines Patent Pool (MPP) announced a licensing agreement for the clinical development of sutezolid, an antibiotic drug candidate which demonstrated encouraging results in early studies. The sublicense pertains to the development of sutezolid in combination with other TB drugs and follows the MPP’s license for

Hope for Africans as the Medicines Patent Pool Announces First Licence for Tuberculosis Treatment

The Medicines Patent Pool has announced signing a licence with Johns Hopkins University to facilitate the clinical development of tuberculosis (TB) drug candidate sutezolid. Long considered a promising investigational treatment, its further development in combination with other drugs, could offer hope to millions of African suffering from TB particularly those that are both drug-sensitive and

Top